Mitsuo Satoh

发表

"Backward Inclined Lining", A New Design for BOF Cone Linings

Shigeki Uchida, Minoru Sutoh, Takashi Miki, 2009 .

Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC

Shinji Hosoi, Kazuya Yamano, Shigeru Iida, 2006, Biotechnology and bioengineering.

Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities.

Tomoaki Nakagawa, Mitsuo Satoh, Masako Wakitani, 2008, Cancer research.

Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity

Shigeru Iida, Mitsuo Satoh, S. Iida, 2004, Biotechnology and bioengineering.

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

Kazuhiro Masuda, Tsunehiro Mizushima, Shigeru Iida, 2011, Genes to cells : devoted to molecular & cellular mechanisms.

A peptidomics strategy for discovering endogenous bioactive peptides.

Naoto Minamino, Noriyuki Takahashi, Mitsuo Satoh, 2010, Journal of proteome research.

Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.

Akira Okazaki, Shigeru Iida, Mitsuo Satoh, 2007, Journal of biotechnology.

Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.

Yoshiki Yamaguchi, Mitsuo Satoh, K. Shitara, 2007, Journal of molecular biology.

Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

Shigeru Iida, Mitsuo Satoh, S. Iida, 2007, BMC Biotechnology.

A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients

Masakazu Toi, Eiji Suzuki, Masahide Kondo, 2007, Clinical Cancer Research.

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.

Akira Okazaki, Mitsuo Satoh, M. Inoue, 2007, Glycobiology.

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA.

Kazuya Yamano, Shigeru Iida, Mitsuo Satoh, 2004, Biotechnology and bioengineering.

IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.

Shigeru Iida, Mitsuo Satoh, S. Iida, 2005, Journal of immunological methods.